p53 expression controls prostate cancer sensitivity to chemotherapy and the MDM2 inhibitor Nutlin-3

  • William H. Chappell
    Department of Microbiology & Immunology; Brody School of Medicine at East Carolina University; Greenville, NC USA
  • Brian D. Lehmann
    Department of Biochemistry; Vanderbilt School of Medicine; Vanderbilt University; Nashville, TN USA
  • David M. Terrian
    Department of Anatomy and Cell Biology; Brody School of Medicine at East Carolina University; Greenville, NC USA
  • Stephen L. Abrams
    Department of Microbiology & Immunology; Brody School of Medicine at East Carolina University; Greenville, NC USA
  • Linda S. Steelman
    Department of Microbiology & Immunology; Brody School of Medicine at East Carolina University; Greenville, NC USA
  • James A. McCubrey
    Department of Microbiology & Immunology; Brody School of Medicine at East Carolina University; Greenville, NC USA

書誌事項

公開日
2012-11-27
DOI
  • 10.4161/cc.22852
公開者
Informa UK Limited

この論文をさがす

収録刊行物

  • Cell Cycle

    Cell Cycle 11 (24), 4579-4588, 2012-11-27

    Informa UK Limited

被引用文献 (3)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ